✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Exact Sciences Corp

Common Name
Exact Sciences
Country
United States
Sector
Healthcare
Industry
Diagnostics & Research
Employees
7,100
Ticker
EXAS
Exchange
NASDAQ CAPITAL MARKET
Description
Exact Sciences Corp is a leading molecular diagnostics company specializing in cancer screening and diagnostic tests. Its flagship product, Cologuard, is a non-invasive stool-based DNA test designed t...

Disclosures of Exact Sciences

Explore Exact Sciences's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Exact Sciences's official channels and fully traceable to its official company sources.

The table below lists all of Exact Sciences's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20246 disclosures
TCFD Report
en
Responsible Business Report
en
SASB index
en
10-K
en
Financial & Extra-Financial Disclosure
Equal employment opportunity (EEO) Report
en
20235 disclosures
ESG Report
en
Financial & Extra-Financial Disclosure
SASB index
en
TCFD Report
en
Annual Report
en
20224 disclosures
ESG Report
en
TCFD Report
en
10-K
en
SASB index
en
20214 disclosures
TCFD Report
en
ESG Report
en
10-K
en
SASB index
en
20202 disclosures
Sustainability Report
10-K
20192 disclosures
10-K
Sustainability Report
20181 disclosure
10-K
20171 disclosure
10-K
20161 disclosure
10-K
20151 disclosure
10-K
20141 disclosure
10-K
20131 disclosure
10-K
20121 disclosure
10-K
20111 disclosure
10-K
20101 disclosure
10-K
20091 disclosure
10-K
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?